Strong quarter for Lundbeck but earnings to fall in 2012
Greece announces compromise on pharma spending
FDA warns of C difficile risk with antiulcerants
Sanofi faces a 15% profit drop from generic competition in 2012
Polish legislative uproar leads to pharma market chaos
World osteoporosis market forecast to reach $11.4B in 2015
Illumina rejects 'opportunistic' Roche offer
Pharma sales flat but GSK pleased with R&D progress
Orexigen agrees trial design for obesity drug with FDA
Pharma fears it is not up to demands of 'value challenge' - EIU
Questions? Tel: 0121 616 5051